“ If we can detect infections early, we can optimize antimicrobial treatment and prevent transmission within our healthcare system. The BD MAX allows us to do that.”

Professor, Nagasaki University

How can you achieveHealthcare-Associated Infections

IMPACT?

Expand your lab’s molecular testing potential

Workflow efficiency for timely patient management1

Diagnostic speed and accuracy to aid in fast, appropriate treatment2

Testing versatility for a wide range of patients3

Visit moleculardiagnostics.bd.com to find out how

• • • • • • • • • • • • • • ••••••••••••••••••••••••

••••••• •• •• •

• • •• • •

1hr 2hr

References: 1. Mortensen JE et al. Comparison of time-motion analysis of conventional stool culture and the BD MAX Enteric Bacterial Panel (EBP). BMC Clin Pathol. 2015;15:9. 2. Bauman M. Transitioning from culture to molecular: implementation and integration of BD Max Enteric Bacterial Panel at Cincinnati Children’s Hospital. ADVANCE Healthcare website. http://laboratory-manager.advanceweb.com/SharedResources/Downloads/2015/051815/bd_advertorial.pdf. Updated June 2015. Accessed June 1, 2016. 3. Felder RA et al. Process evaluation of an open architecture real-time molecular laboratory platform. J Lab Autom. 2014;19(5):468-473. 4. Active Bacterial Core Surveillance (ABCs) Report Emerging Infections Program Network Methicillin-Resistant Staphylococcus aureus, 2014. https://www.cdc.gov/abcs/reports- findings/survreports/mrsa14.pdf 5. McGarry, et al. Surgical-Site Infection Due to Staphylococcus aureus Among Elderly Patients: Mortality, Duration of Hospitalization, and Cost. Infection Control and Hospital Epide-miology 2004; 25:6. 6. CDC Biggest Threats, February 25, 2015 https://www.cdc.gov/drugresistance /biggest_threats.html (Clostridium difficile tab)

Why BD?The BD MAX™ System delivers automated extraction, amplification, and detection of the most common HAIs, with up to 24 patient results in just over 2 hours.

Setting higher standards in the fight against HAIs

Why change?

~55,000 patientscontracted an MRSA infection

while hospitalized4

~15,000 patientdeaths

from CDI6

Patients with an MRSA surgical site infection

have up to 11 times higher rate of mortality5

BD MAX™ StaphSR:A pre-surgical screening test for nasal carriage of Staphylococcus aureus or MRSA to aid in transmission prevention and infection control. The assay offers the same level of comprehensive coverage as the BD MAX MRSA XT assay, including detection of the 11 MREJ regions, mecA drop-out mutants and the newly emerging mecC gene.

BD MAX™ Cdiff:A test for patients suspected of having Clostridium difficile infection (CDI) through the detection of the C difficile toxin B gene (tcdB) from liquid or soft stool. The assay provides a highly accurate result in an actionable timeframe and requires limited hands-on time as compared to traditional methods.

BD MAX™ MRSA XT :A screening test for nasal carriage of MRSA aiding in transmission prevention and infection control. The assay provides comprehensive coverage of 11 sequences of the SCCmec-orfX right-extremity junction (MREJ) region plus identification of mecA drop-out mutants and detection of the newly emerging mecC gene.

The BD MAX System is a single platform capable of running BD and partner developed assays, as well as laboratory-developed tests (LDTs).

Start maximizing your impact Contact your Local Representative

Why now?Because when early and accurate detection of HAIs is combined with appropriate infection control interventions and patient treatment, we can support antimicrobial stewardship initiatives, prevent transmission, and improve patient management to reduce the financial burden on healthcare systems.

Women’s Health and STIs

• CT/GC/TV• GBS• Vaginal Panel

Enteric Solutions• Enteric Bacterial Panel• Enteric Parasite Panel• Extended Enteric Bacterial Panel

Open-System Reagents

• DNA or TNA Extraction• DNA or TNA Amplification

bd.com© 2018 BD. BD, the BD Logo and BD MAX are trademarks of Becton, Dickinson and Company. 1-223883-US June 2018.

BD, Sparks, MD 21152-0999 USA800.638.8663